Literature DB >> 1127576

Pharmacokinetics of theophylline in relation to increased pain sensitivity in the rat.

L K Paalzow.   

Abstract

In the rat, theophylline increases, in proporation to dose, the sensitivity to painful stimulation. A study of the pharmacological registration of this property combined with the determination of drug... levels in plasma indicated that theophylline behaves according to a two-compartment open modelmby relating the pharmacological activities to the drug level data using different pharmacokinetic types of calculation, it was concluded that the site of action of theophylline in the central nervous system lies closer to the central (plasma) compartment than to the peripheral one. The registered pharmacological effects of theophylline are thus directly reflected by the plasma concentration of this drug.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1127576     DOI: 10.1007/bf01066593

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  14 in total

1.  Observations on the neuropharmacology of morphine and morphinelike analgesia.

Authors:  M N CARROLL; R K LIM
Journal:  Arch Int Pharmacodyn Ther       Date:  1960-05-01

2.  Absorption, distribution, and elimination of spectinomycin dihydrochloride in man.

Authors:  J G Wagner; E Novak; L G Leslie; C M Metzler
Journal:  Int Z Klin Pharmakol Ther Toxikol       Date:  1968-04

3.  Theophylline increased sensitivity to nociceptive stimulation and regional turnover of rat brain 5-HT, noradrenaline and dopamine.

Authors:  G Paalzow; L Paalzow
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1974-03

4.  Determination of theophylline and probenecid in biological material.

Authors:  A Arbin; P O Edlund
Journal:  Acta Pharm Suec       Date:  1974-06

5.  Rapidly achieved plasma concentration plateaus, with observations on theophylline kinetics.

Authors:  P A Mitenko; R I Ogilvie
Journal:  Clin Pharmacol Ther       Date:  1972 May-Jun       Impact factor: 6.875

6.  Concept of a volume of distribution and possible errors in evaluation of this parameter.

Authors:  S Riegelman; J Loo; M Rowland
Journal:  J Pharm Sci       Date:  1968-01       Impact factor: 3.534

7.  Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment.

Authors:  S Riegelman; J C Loo; M Rowland
Journal:  J Pharm Sci       Date:  1968-01       Impact factor: 3.534

8.  Quantitative determination of drug bioavailability and biokinetic behavior from pharmacological data for ophthalmic and oral administrations of a mydriatic drug.

Authors:  V F Smolen
Journal:  J Pharm Sci       Date:  1971-03       Impact factor: 3.534

9.  Commentary. Drug distribution and pharmacologic effects.

Authors:  M Gibaldi; G Levy; H Weintraub
Journal:  Clin Pharmacol Ther       Date:  1971 Sep-Oct       Impact factor: 6.875

Review 10.  Pharmacokinetics of drug action.

Authors:  G Levy; M Gibaldi
Journal:  Annu Rev Pharmacol       Date:  1972       Impact factor: 13.820

View more
  3 in total

1.  Tissue content of adenosine, inosine and hypoxanthine in the rat kidney after ischemia and postischemic recirculation.

Authors:  H Osswald; H J Schmitz; R Kemper
Journal:  Pflugers Arch       Date:  1977-10-19       Impact factor: 3.657

Review 2.  Cellular and molecular mechanism(s) of coronary flow regulation by adenosine.

Authors:  S J Mustafa
Journal:  Mol Cell Biochem       Date:  1980-06-18       Impact factor: 3.396

3.  Well-tempered MCMC simulations for population pharmacokinetic models.

Authors:  Frederic Y Bois; Nan-Hung Hsieh; Wang Gao; Weihsueh A Chiu; Brad Reisfeld
Journal:  J Pharmacokinet Pharmacodyn       Date:  2020-07-31       Impact factor: 2.745

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.